High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
Carsten Linnemann(The Netherlands Cancer Institute), Ton N. Schumacher(Leiden University Medical Center), Marit M. van Buuren(The Netherlands Cancer Institute), John B.A.G. Haanen(B. J. Medical College & Sassoon Hospital), Dris El Atmioui(The Netherlands Cancer Institute), Henk Hilkmann(The Netherlands Cancer Institute), Sjoerd H. van der Burg(Leiden University Medical Center), Michael R. Stratton(Wellcome Sanger Institute), Els M.E. Verdegaal(Leiden University Medical Center), Arno Velds(The Netherlands Cancer Institute), Laura Bies(The Netherlands Cancer Institute), Sam Behjati(University of Cambridge), Marten Visser(Leiden University Medical Center), Hergen Spits(The Netherlands Cancer Institute), Jorg J. A. Calis(Utrecht University), Remko Schotte(AIMM Therapeutics (Netherlands))
Cited by 692
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
The cancer genome
|Nature|2009|3.5k
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
|Nucleic Acids Research|2014|2.4k